TANG CAPITAL PARTNERS LP

10% owner at Ardea Biosciences, Inc./DE · on record since Mar 31, 2006
10% owner at Rain Oncology Inc. · on record since Jun 1, 2023
10% owner at TAPESTRY PHARMACEUTICALS, INC · on record since May 25, 2006
10% owner at Molecular Templates, Inc. · on record since Aug 21, 2006
10% owner at ARADIGM CORP · on record since Jan 29, 2007
10% owner at Singular Genomics Systems, Inc. · on record since Sep 18, 2024
10% owner at HERON THERAPEUTICS, INC. /DE/ · on record since Jun 18, 2007
10% owner at Assertio Therapeutics, Inc · on record since Jan 28, 2008
10% owner at Northstar Neuroscience, Inc. · on record since Apr 28, 2008
10% owner at NEOSE TECHNOLOGIES INC · on record since Sep 30, 2008
10% owner at Vanda Pharmaceuticals Inc. · on record since Sep 29, 2008
10% owner at PENWEST PHARMACEUTICALS CO · on record since Feb 27, 2009
Director at HERON THERAPEUTICS, INC. /DE/ · on record since May 26, 2010
10% owner at Mirati Therapeutics, Inc. · on record since Sep 23, 2013
10% owner at LA JOLLA PHARMACEUTICAL CO · on record since Sep 26, 2014
10% owner at ACLARA BIOSCIENCES INC · on record since Dec 14, 2004
10% owner at Bio Green Med Solution, Inc. · on record since Feb 27, 2017
10% owner at Odonate Therapeutics, Inc. · on record since Dec 8, 2017
10% owner at · on record since Nov 6, 2020
Exit Filing at · on record since Nov 26, 2021
10% owner at · on record since Mar 14, 2023
10% owner at · on record since May 30, 2023

Insider trading activity of TANG CAPITAL PARTNERS LP

Transactions on record: 201; since Dec 14, 2004

Open-market buys: 153; $181.2M

Open-market sells: 29; $21M

Companies traded: 16; last filing Feb 14, 2024

Figures computed from official regulatory filings — .

Track record of TANG CAPITAL PARTNERS LP

Statistical track record

Free account

Open-market buys: 154

Last buy: May 25, 2023

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of TANG CAPITAL PARTNERS LP

Co-insiders of TANG CAPITAL PARTNERS LP

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
TCR2 THERAPEUTICS INC.Listing unverified	Feb 14, 2024	Other	-4,394,800	—	n/a (No price was disclosed in the filing)		SEC
Rain Oncology Inc.Listing unverified	Feb 2, 2024	Other	-3,850,513	—	n/a (No price was disclosed in the filing)		SEC
Rain Oncology Inc.Listing unverified	Dec 18, 2023	Sell	-24,406	1.21 USD	$29.5K		SEC
Rain Oncology Inc.Listing unverified	Dec 18, 2023	Sell	-109,435	1.20 USD	$131.3K		SEC
Rain Oncology Inc.Listing unverified	Dec 18, 2023	Sell	-40,132	1.21 USD	$48.6K		SEC
TCR2 THERAPEUTICS INC.Listing unverified	May 30, 2023	Buy	50,000	1.72 USD	$86K	conv 20	SEC
TCR2 THERAPEUTICS INC.Listing unverified	May 10, 2023	Buy	6,774	1.95 USD	$13.2K	conv 19	SEC
TCR2 THERAPEUTICS INC.Listing unverified	May 10, 2023	Buy	57,073	1.95 USD	$111.3K	conv 20	SEC
TCR2 THERAPEUTICS INC.Listing unverified	May 10, 2023	Buy	20,141	1.95 USD	$39.3K	conv 20	SEC
TCR2 THERAPEUTICS INC.Listing unverified	May 5, 2023	Buy	104,241	1.86 USD	$193.9K	conv 20	SEC
TCR2 THERAPEUTICS INC.Listing unverified	May 5, 2023	Buy	71,064	1.94 USD	$137.9K	conv 20	SEC
TCR2 THERAPEUTICS INC.Listing unverified	May 5, 2023	Buy	95,759	1.90 USD	$181.9K	conv 20	SEC
TCR2 THERAPEUTICS INC.Listing unverified	May 5, 2023	Buy	18,513	1.85 USD	$34.2K	conv 33First in 12mo	SEC
LA JOLLA PHARMACEUTICAL COListing unverified	Dec 1, 2021	Sell	-136,255	3.76 USD	$512.3K		SEC
LA JOLLA PHARMACEUTICAL COListing unverified	Dec 1, 2021	Sell	-6,597	3.95 USD	$26.1K		SEC
LA JOLLA PHARMACEUTICAL COListing unverified	Dec 1, 2021	Sell	-41,290	3.66 USD	$151.1K		SEC
LA JOLLA PHARMACEUTICAL COListing unverified	Dec 1, 2021	Sell	-63,745	3.95 USD	$251.8K		SEC
LA JOLLA PHARMACEUTICAL COListing unverified	Dec 1, 2021	Sell	-193,403	4.10 USD	$793K		SEC
Aptevo Therapeutics Inc.Listing on record	Nov 26, 2021	Sell	-200,000	10.07 USD	$2M	Unusual size	SEC
Aptevo Therapeutics Inc.Listing on record	Nov 26, 2021	Sell	-50,889	10.43 USD	$530.8K		SEC
Aptevo Therapeutics Inc.Listing on record	Nov 26, 2021	Sell	-160,000	9.60 USD	$1.5M		SEC
Aptevo Therapeutics Inc.Listing on record	Nov 26, 2021	Sell	-161,336	13.52 USD	$2.2M	Unusual size	SEC
Aptevo Therapeutics Inc.Listing on record	Nov 26, 2021	Sell	-124,509	12.45 USD	$1.6M		SEC
Aptevo Therapeutics Inc.Listing on record	Nov 26, 2021	Sell	-75,491	11.74 USD	$886.3K		SEC
Aptevo Therapeutics Inc.Listing on record	Nov 26, 2021	Sell	-149,111	11.19 USD	$1.7M	Unusual size	SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
TCR2 THERAPEUTICS INC.Listing unverified	Feb 14, 2024	Other	-4,394,800	—	n/a (No price was disclosed in the filing)		SEC
Rain Oncology Inc.Listing unverified	Feb 2, 2024	Other	-3,850,513	—	n/a (No price was disclosed in the filing)		SEC
Rain Oncology Inc.Listing unverified	Dec 18, 2023	Sell	-24,406	1.21 USD	$29.5K		SEC
Rain Oncology Inc.Listing unverified	Dec 18, 2023	Sell	-109,435	1.20 USD	$131.3K		SEC
Rain Oncology Inc.Listing unverified	Dec 18, 2023	Sell	-40,132	1.21 USD	$48.6K		SEC
TCR2 THERAPEUTICS INC.Listing unverified	May 30, 2023	Buy	50,000	1.72 USD	$86K	conv 20	SEC
TCR2 THERAPEUTICS INC.Listing unverified	May 10, 2023	Buy	6,774	1.95 USD	$13.2K	conv 19	SEC
TCR2 THERAPEUTICS INC.Listing unverified	May 10, 2023	Buy	57,073	1.95 USD	$111.3K	conv 20	SEC
TCR2 THERAPEUTICS INC.Listing unverified	May 10, 2023	Buy	20,141	1.95 USD	$39.3K	conv 20	SEC
TCR2 THERAPEUTICS INC.Listing unverified	May 5, 2023	Buy	104,241	1.86 USD	$193.9K	conv 20	SEC
TCR2 THERAPEUTICS INC.Listing unverified	May 5, 2023	Buy	71,064	1.94 USD	$137.9K	conv 20	SEC
TCR2 THERAPEUTICS INC.Listing unverified	May 5, 2023	Buy	95,759	1.90 USD	$181.9K	conv 20	SEC
TCR2 THERAPEUTICS INC.Listing unverified	May 5, 2023	Buy	18,513	1.85 USD	$34.2K	conv 33First in 12mo	SEC
LA JOLLA PHARMACEUTICAL COListing unverified	Dec 1, 2021	Sell	-136,255	3.76 USD	$512.3K		SEC
LA JOLLA PHARMACEUTICAL COListing unverified	Dec 1, 2021	Sell	-6,597	3.95 USD	$26.1K		SEC
LA JOLLA PHARMACEUTICAL COListing unverified	Dec 1, 2021	Sell	-41,290	3.66 USD	$151.1K		SEC
LA JOLLA PHARMACEUTICAL COListing unverified	Dec 1, 2021	Sell	-63,745	3.95 USD	$251.8K		SEC
LA JOLLA PHARMACEUTICAL COListing unverified	Dec 1, 2021	Sell	-193,403	4.10 USD	$793K		SEC
Aptevo Therapeutics Inc.Listing on record	Nov 26, 2021	Sell	-200,000	10.07 USD	$2M	Unusual size	SEC
Aptevo Therapeutics Inc.Listing on record	Nov 26, 2021	Sell	-50,889	10.43 USD	$530.8K		SEC
Aptevo Therapeutics Inc.Listing on record	Nov 26, 2021	Sell	-160,000	9.60 USD	$1.5M		SEC
Aptevo Therapeutics Inc.Listing on record	Nov 26, 2021	Sell	-161,336	13.52 USD	$2.2M	Unusual size	SEC
Aptevo Therapeutics Inc.Listing on record	Nov 26, 2021	Sell	-124,509	12.45 USD	$1.6M		SEC
Aptevo Therapeutics Inc.Listing on record	Nov 26, 2021	Sell	-75,491	11.74 USD	$886.3K		SEC
Aptevo Therapeutics Inc.Listing on record	Nov 26, 2021	Sell	-149,111	11.19 USD	$1.7M	Unusual size	SEC

TANG CAPITAL PARTNERS LP

Insider trading activity of TANG CAPITAL PARTNERS LP

Companies where TANG CAPITAL PARTNERS LP has traded

Track record of TANG CAPITAL PARTNERS LP

Transaction history of TANG CAPITAL PARTNERS LP

Co-insiders of TANG CAPITAL PARTNERS LP

TANG CAPITAL PARTNERS LP

Insider trading activity of TANG CAPITAL PARTNERS LP

Companies where TANG CAPITAL PARTNERS LP has traded

Track record of TANG CAPITAL PARTNERS LP

Transaction history of TANG CAPITAL PARTNERS LP

Co-insiders of TANG CAPITAL PARTNERS LP